170 related articles for article (PubMed ID: 32628355)
1. Genome-wide DNA methylome analysis reveals methylation subtypes with different clinical outcomes for acute myeloid leukemia patients.
Gao H; He X; Li Q; Wang Y; Tian Y; Chen X; Wang J; Guo Y; Wang W; Li X
Cancer Med; 2020 Sep; 9(17):6296-6305. PubMed ID: 32628355
[TBL] [Abstract][Full Text] [Related]
2. Base-pair resolution DNA methylation sequencing reveals profoundly divergent epigenetic landscapes in acute myeloid leukemia.
Akalin A; Garrett-Bakelman FE; Kormaksson M; Busuttil J; Zhang L; Khrebtukova I; Milne TA; Huang Y; Biswas D; Hess JL; Allis CD; Roeder RG; Valk PJ; Löwenberg B; Delwel R; Fernandez HF; Paietta E; Tallman MS; Schroth GP; Mason CE; Melnick A; Figueroa ME
PLoS Genet; 2012; 8(6):e1002781. PubMed ID: 22737091
[TBL] [Abstract][Full Text] [Related]
3. Hypermethylation of the GATA binding protein 4 (GATA4) promoter in Chinese pediatric acute myeloid leukemia.
Tao YF; Fang F; Hu SY; Lu J; Cao L; Zhao WL; Xiao PF; Li ZH; Wang NN; Xu LX; Du XJ; Sun LC; Li YH; Li YP; Xu YY; Ni J; Wang J; Feng X; Pan J
BMC Cancer; 2015 Oct; 15():756. PubMed ID: 26490736
[TBL] [Abstract][Full Text] [Related]
4. Differential methylation in CN-AML preferentially targets non-CGI regions and is dictated by DNMT3A mutational status and associated with predominant hypomethylation of HOX genes.
Qu Y; Lennartsson A; Gaidzik VI; Deneberg S; Karimi M; Bengtzén S; Höglund M; Bullinger L; Döhner K; Lehmann S
Epigenetics; 2014 Aug; 9(8):1108-19. PubMed ID: 24866170
[TBL] [Abstract][Full Text] [Related]
5. Region-Specific Methylation Profiling in Acute Myeloid Leukemia.
Cecotka A; Polanska J
Interdiscip Sci; 2018 Mar; 10(1):33-42. PubMed ID: 29405013
[TBL] [Abstract][Full Text] [Related]
6. Identification of differentially methylated markers among cytogenetic risk groups of acute myeloid leukemia.
Qu X; Davison J; Du L; Storer B; Stirewalt DL; Heimfeld S; Estey E; Appelbaum FR; Fang M
Epigenetics; 2015; 10(6):526-35. PubMed ID: 25996682
[TBL] [Abstract][Full Text] [Related]
7. Genome wide analysis of acute myeloid leukemia reveal leukemia specific methylome and subtype specific hypomethylation of repeats.
Saied MH; Marzec J; Khalid S; Smith P; Down TA; Rakyan VK; Molloy G; Raghavan M; Debernardi S; Young BD
PLoS One; 2012; 7(3):e33213. PubMed ID: 22479372
[TBL] [Abstract][Full Text] [Related]
8. DNA methylation-based subtypes of acute myeloid leukemia with distinct prognosis and clinical features.
Jian J; Yuan C; Ji C; Hao H; Lu F
Clin Exp Med; 2023 Oct; 23(6):2639-2649. PubMed ID: 36645547
[TBL] [Abstract][Full Text] [Related]
9. Prognostic methylation markers for overall survival in cytogenetically normal patients with acute myeloid leukemia treated on SWOG trials.
Qu X; Othus M; Davison J; Wu Y; Yan L; Meshinchi S; Ostronoff F; Estey EH; Radich JP; Erba HP; Appelbaum FR; Fang M
Cancer; 2017 Jul; 123(13):2472-2481. PubMed ID: 28222251
[TBL] [Abstract][Full Text] [Related]
10. Aberrant DNA methylation of acute myeloid leukemia and colorectal cancer in a Chinese pedigree with a MLL3 germline mutation.
Yang F; Gong Q; Shi W; Zou Y; Shi J; Wei F; Li Q; Chen J; Li WD
Tumour Biol; 2016 Sep; 37(9):12609-12618. PubMed ID: 27405564
[TBL] [Abstract][Full Text] [Related]
11. Combined testing for CCAAT/enhancer-binding protein alpha (CEBPA) mutations and promoter methylation in acute myeloid leukemia demonstrates shared phenotypic features.
Szankasi P; Ho AK; Bahler DW; Efimova O; Kelley TW
Leuk Res; 2011 Feb; 35(2):200-7. PubMed ID: 20970189
[TBL] [Abstract][Full Text] [Related]
12. Clinical implications of aberrant DNA methylation patterns in acute myelogenous leukemia.
Galm O; Wilop S; Lüders C; Jost E; Gehbauer G; Herman JG; Osieka R
Ann Hematol; 2005 Dec; 84 Suppl 1():39-46. PubMed ID: 16231140
[TBL] [Abstract][Full Text] [Related]
13. Genome-wide regulation of CpG methylation by ecCEBPα in acute myeloid leukemia.
Ogunleye AJ; Romanova E; Medvedeva YA
F1000Res; 2021; 10():204. PubMed ID: 34557292
[No Abstract] [Full Text] [Related]
14. Developing DNA methylation-based prognostic biomarkers of acute myeloid leukemia.
Gao C; Zhuang J; Zhou C; Liu L; Liu C; Li H; Zhao M; Liu G; Sun C
J Cell Biochem; 2018 Dec; 119(12):10041-10050. PubMed ID: 30171717
[TBL] [Abstract][Full Text] [Related]
15. NDRG2 and TLR7 as novel DNA methylation prognostic signatures for acute myelocytic leukemia.
Ge F; Zhang P; Niu J; Pei X; Lian C; Yu R; Ma R; Zhang Y; Zhu Z; Sun K
J Cell Physiol; 2020 Apr; 235(4):3790-3797. PubMed ID: 31613009
[TBL] [Abstract][Full Text] [Related]
16. MN1 overexpression is driven by loss of DNMT3B methylation activity in inv(16) pediatric AML.
Larmonie NSD; Arentsen-Peters TCJM; Obulkasim A; Valerio D; Sonneveld E; Danen-van Oorschot AA; de Haas V; Reinhardt D; Zimmermann M; Trka J; Baruchel A; Pieters R; van den Heuvel-Eibrink MM; Zwaan CM; Fornerod M
Oncogene; 2018 Jan; 37(1):107-115. PubMed ID: 28892045
[TBL] [Abstract][Full Text] [Related]
17. Aberrant CpG island methylation in acute myeloid leukemia is accentuated at relapse.
Kroeger H; Jelinek J; Estécio MR; He R; Kondo K; Chung W; Zhang L; Shen L; Kantarjian HM; Bueso-Ramos CE; Issa JP
Blood; 2008 Aug; 112(4):1366-73. PubMed ID: 18523155
[TBL] [Abstract][Full Text] [Related]
18. Quantitative DNA methylation predicts survival in adult acute myeloid leukemia.
Bullinger L; Ehrich M; Döhner K; Schlenk RF; Döhner H; Nelson MR; van den Boom D
Blood; 2010 Jan; 115(3):636-42. PubMed ID: 19903898
[TBL] [Abstract][Full Text] [Related]
19. Differential methylation pattern of ID4, SFRP1, and SHP1 between acute myeloid leukemia and chronic myeloid leukemia.
Uhm KO; Lee ES; Lee YM; Park JS; Kim SJ; Kim BS; Kim HS; Park SH
J Korean Med Sci; 2009 Jun; 24(3):493-7. PubMed ID: 19543515
[TBL] [Abstract][Full Text] [Related]
20. Clinical implications of genome-wide DNA methylation studies in acute myeloid leukemia.
Li Y; Xu Q; Lv N; Wang L; Zhao H; Wang X; Guo J; Chen C; Li Y; Yu L
J Hematol Oncol; 2017 Feb; 10(1):41. PubMed ID: 28153026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
